AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
57.11M
Enterprise Value 3
51.12M
Trailing P/E
N/A
Forward P/E 1
-2.12
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
12.41
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-4.03

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-35.12%
S&P500 52-Week Change 314.45%
52 Week High 31.3100
52 Week Low 30.2600
50-Day Moving Average 30.4347
200-Day Moving Average 30.4658

Share Statistics

Avg Vol (3 month) 3732.81k
Avg Vol (10 day) 3387.57k
Shares Outstanding 5158.64M
Float 134.2M
% Held by Insiders 110.71%
% Held by Institutions 122.68%
Shares Short (Oct 31, 2019) 49.94M
Short Ratio (Oct 31, 2019) 414.78
Short % of Float (Oct 31, 2019) 46.36%
Short % of Shares Outstanding (Oct 31, 2019) 46.27%
Shares Short (prior month Sep 30, 2019) 415.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/1
Last Split Date 3Aug 1, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.36%
Return on Equity (ttm)-347.81%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.68M
Net Income Avi to Common (ttm)-11.08M
Diluted EPS (ttm)-0.0780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.04M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)1.53M
Total Debt/Equity (mrq)36.97
Current Ratio (mrq)4.15
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-12.96M
Levered Free Cash Flow (ttm)-8.3M